A minimally invasive procedure called genicular artery embolization (GAE) may offer a new treatment option for individuals experiencing chronic knee pain from osteoarthritis. This outpatient procedure aims to reduce inflammation and pain without requiring major surgery. It could serve as a middle ground between conservative treatments and total knee replacement.
Genicular artery embolization works by reducing blood flow to inflamed areas within the knee. A small incision is made to guide a catheter through the femoral artery using X-ray imaging. Tiny beads are then released into specific blood vessels around the knee. These beads reduce blood flow to painful, inflamed regions.
Patients with mild to moderate knee osteoarthritis are often the best candidates for GAE. The procedure typically takes one to two hours under conscious sedation. Recovery is generally shorter than with knee replacement surgery. Patients are monitored for several hours and usually return home the same day.
Early research on GAE has shown encouraging results. Some patients report significant pain reduction, with some achieving little to no pain. Data from Japan suggests pain relief may last up to four years. Two-year data from the United States indicates similar lasting benefits for responders. The Food and Drug Administration (FDA) has granted "breakthrough device status" to devices used in this area. This designation aims to accelerate the development and review of medical technologies offering significant patient advantages.
Researchers at the University of Colorado Anschutz School of Medicine are conducting clinical trials to further understand GAE's effects. One study investigates changes in knee fluid to understand how the procedure impacts inflammation. Another study evaluates a temporary treatment device called Nexsphere-F. This device temporarily blocks small blood vessels in the knee that contribute to pain and inflammation.
While currently used for knees, similar approaches are being explored for other painful conditions. These include frozen shoulder, tennis elbow, and plantar fasciitis. If ongoing studies continue to demonstrate lasting benefits, GAE could become a vital option for patients seeking alternatives to major joint surgery.
Related stories
Dreaming May Deplete Brain Energy Despite Increased Fuel Supply
New research indicates that dreaming during REM sleep may consume significant brain energy, with neuronal energy levels dropping despite an increase in the brain's fuel supply.
Tirzepatide May Activate Calorie-Burning Brown Fat
A mouse study suggests tirzepatide, sold as Mounjaro and Zepbound, may activate calorie-burning brown fat, offering a new understanding of its metabolic benefits.
ADHD and Autism Diagnoses Show Shifting Demographics in Denmark
A large Danish study found that children diagnosed with ADHD or autism now more closely resemble the general population, suggesting broader identification rather than only an increase in underlying conditions.